世界のペプチド合成市場は、2021年の5億1500万ドルから2026年までに7億3000万ドルに達し、2021年から2026年までのCAGRは7.2%と予想されます。この市場の成長を促す要因としては、医薬品におけるペプチドの使用の増加、研究活動の活発化と潤沢な研究開発資金、先進的な自動ペプチド合成装置の開発が挙げられます。ただし、治療用ペプチドの統一された規制の欠如と高額な機器のコストが予測期間中におけるこの市場の成長を抑制する可能性があります。
WHOによると、COVID-19の確定症例数は271,963,258例で、そのうち死亡者数は5,331,019例でした(2021年12月17日現在)。死亡者数が最も多かったのは南北アメリカで、ヨーロッパと東南アジアがそれに続きました。
COVID-19パンデミックによって、主要な製薬およびバイオテクノロジー企業とペプチド合成市場のプレーヤーは、治療用およびペプチドベースのワクチンの研究開発への投資を促されました。ワクチンとペプチドベースの薬剤の需要が高まったことによって、ペプチド合成が最前線に立たされました。ペプチドは特定の標的に対する選択性と特異性という独自の特徴を示しているため、ペプチドベースのアプローチはターニングポイントを表しています。CoVac-1は、COVID-19と戦うための深いSARS-CoV-2T細胞免疫の誘導を目的として、さまざまなウイルスタンパク質に由来するSARS-CoV-2 T細胞エピトープと、Montanide ISA51 VGに乳化されたToll様受容体1/2アゴニストXS15を組み合わせた、ペプチドベースのワクチン候補です。このような進歩によって、ペプチドを製造するための試薬および装置の需要が高まっています。
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 34)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 38)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: PEPTIDE SYNTHESIS MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 PEPTIDE SYNTHESIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2020
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2020
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 6 PEPTIDE SYNTHESIS MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
FIGURE 7 PEPTIDE SYNTHESIS MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS
2.4 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.5.1 COVID-19-SPECIFIC ASSUMPTIONS
2.6 RISK ANALYSIS
3 EXECUTIVE SUMMARY (Page No. - 48)
FIGURE 9 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
FIGURE 10 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
FIGURE 11 PEPTIDE SYNTHESIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE PEPTIDE SYNTHESIS MARKET
4 PREMIUM INSIGHTS (Page No. - 51)
4.1 PEPTIDE SYNTHESIS MARKET OVERVIEW
FIGURE 13 INCREASING USE OF PEPTIDES IN PHARMACEUTICAL DRUGS AND INCREASING RESEARCH ACTIVITIES TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE AND COUNTRY (2020)
FIGURE 14 REAGENTS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN PEPTIDE SYNTHESIS MARKET IN 2020
4.3 PEPTIDE SYNTHESIS MARKET SHARE, BY TECHNOLOGY (2020)
FIGURE 15 SOLID-PHASE PEPTIDE SYNTHESIS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
4.4 PEPTIDE SYNTHESIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES WILL CONTINUE TO DOMINATE THE MARKET IN 2026
4.5 PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH IN THE PEPTIDE SYNTHESIS MARKET FROM 2021 TO 2026
5 MARKET OVERVIEW (Page No. - 55)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 PEPTIDE SYNTHESIS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Increasing use of peptides in pharmaceutical drugs
TABLE 2 PEPTIDE-BASED DRUGS APPROVED BY THE FOOD AND DRUG ADMINISTRATION (FDA) (2015-2019)
TABLE 3 KEY SYNTHETIC PEPTIDES IN DEVELOPMENT FOR COVID-19
5.2.1.2 Increase in research activities and the availability of funding for R&D
FIGURE 19 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012-2026
5.2.1.3 Development of advanced automated peptide synthesizers
5.2.2 RESTRAINTS
5.2.2.1 Lack of a unified set of regulations for therapeutic peptides
5.2.2.2 High cost of instruments
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets in the Asia Pacific region
5.2.3.2 Development of personalized medicines
5.2.4 CHALLENGES
5.2.4.1 Issues associated with the route of administration of peptide drugs
5.2.4.2 Addressing the environmental impact of chemical synthesis of peptides
5.3 RANGES/SCENARIOS
FIGURE 20 SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE PEPTIDE SYNTHESIS MARKET
5.4 IMPACT OF THE COVID-19 OUTBREAK ON THE PEPTIDE SYNTHESIS MARKET
FIGURE 21 PEPTIDE SYNTHESIS SCENARIO PRE AND POST COVID-19
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.6 VALUE CHAIN ANALYSIS
FIGURE 22 VALUE CHAIN ANALYSIS OF THE PEPTIDE SYNTHESIS MARKET: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
5.7 TECHNOLOGICAL ANALYSIS
TABLE 4 COMPARISON OF PEPTIDE SYNTHESIS TECHNOLOGIES
5.8 PATENT ANALYSIS
FIGURE 23 PATENT APPLICATIONS FOR THE PEPTIDE SYNTHESIS MARKET, JANUARY 2011-DECEMBER 2021
TABLE 5 INDICATIVE LIST OF PATENTS IN THE PEPTIDE SYNTHESIS MARKET
5.9 ECOSYSTEM ANALYSIS OF THE PEPTIDE SYNTHESIS MARKET
TABLE 6 SUPPLY CHAIN ECOSYSTEM
5.10 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 PEPTIDE SYNTHESIS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.10.1 THREAT OF NEW ENTRANTS
5.10.2 THREAT OF SUBSTITUTES
5.10.3 BARGAINING POWER OF SUPPLIERS
5.10.4 BARGAINING POWER OF BUYERS
5.10.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.11 REGULATORY ANALYSIS
6 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE (Page No. - 75)
6.1 INTRODUCTION
TABLE 8 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
6.2 REAGENTS
TABLE 9 PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 10 PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 11 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 12 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 13 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 14 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
6.2.1 RESINS
6.2.1.1 Increasing adoption of solid-phase peptide synthesis technology to boost the market for resins
TABLE 15 PEPTIDE SYNTHESIS RESINS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 16 NORTH AMERICA: PEPTIDE SYNTHESIS RESINS MARKE, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 17 EUROPE: PEPTIDE SYNTHESIS RESINS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 18 ASIA PACIFIC: PEPTIDE SYNTHESIS RESINS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 19 LATIN AMERICA: PEPTIDE SYNTHESIS RESINS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
6.2.2 AMINO ACIDS
6.2.2.1 Amino acids are the basic building blocks for peptide synthesis
TABLE 20 PEPTIDE SYNTHESIS AMINO ACIDS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 21 NORTH AMERICA: PEPTIDE SYNTHESIS AMINO ACIDS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 22 EUROPE: PEPTIDE SYNTHESIS AMINO ACIDS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 23 ASIA PACIFIC: PEPTIDE SYNTHESIS AMINO ACIDS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 24 LATIN AMERICA: PEPTIDE SYNTHESIS AMINO ACIDS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
6.2.3 COUPLING REAGENTS
6.2.3.1 Coupling reagents play a vital role in the peptide bond formation
TABLE 25 PEPTIDE SYNTHESIS COUPLING REAGENTS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 26 NORTH AMERICA: PEPTIDE SYNTHESIS COUPLING REAGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 27 EUROPE: PEPTIDE SYNTHESIS COUPLING REAGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 28 ASIA PACIFIC: PEPTIDE SYNTHESIS COUPLING REAGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 29 LATIN AMERICA: PEPTIDE SYNTHESIS COUPLING REAGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
6.2.4 DYES & FLUORESCENT LABELING REAGENTS
6.2.4.1 Fluorescent labeling reagents are crucial to understand the success rate of peptide synthesis reactions
TABLE 30 PEPTIDE SYNTHESIS DYES & FLUORESCENT LABELING REAGENTS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 31 NORTH AMERICA: PEPTIDE SYNTHESIS DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 32 EUROPE: PEPTIDE SYNTHESIS DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 33 ASIA PACIFIC: PEPTIDE SYNTHESIS DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 34 LATIN AMERICA: PEPTIDE SYNTHESIS DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
6.2.5 OTHER REAGENTS
TABLE 35 PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY REGION, 2019-2026 (USD MILLION)
TABLE 36 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 37 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 38 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 39 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
6.3 EQUIPMENT
TABLE 40 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 41 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 42 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 43 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 44 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 45 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
6.3.1 PEPTIDE SYNTHESIZERS
6.3.1.1 Rising automation in peptide synthesizers to drive market growth
TABLE 46 MAJOR PEPTIDE SYNTHESIZERS AVAILABLE IN THE MARKET
TABLE 47 PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 48 NORTH AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 49 EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 50 ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 51 LATIN AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
6.3.2 CHROMATOGRAPHY EQUIPMENT
6.3.2.1 Reverse-phase HPLC is used for the purification of synthetic peptides
TABLE 52 PEPTIDE SYNTHESIS CHROMATOGRAPHY EQUIPMENT MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 53 NORTH AMERICA: PEPTIDE SYNTHESIS CHROMATOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 54 EUROPE: PEPTIDE SYNTHESIS CHROMATOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 55 ASIA PACIFIC: PEPTIDE SYNTHESIS CHROMATOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 56 LATIN AMERICA: PEPTIDE SYNTHESIS CHROMATOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
6.3.3 LYOPHILIZERS
6.3.3.1 Lyophilization enables longer shelf life and eases the transportation of peptides
TABLE 57 PEPTIDE SYNTHESIS LYOPHILIZERS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 58 NORTH AMERICA: PEPTIDE SYNTHESIS LYOPHILIZERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 59 EUROPE: PEPTIDE SYNTHESIS LYOPHILIZERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 60 ASIA PACIFIC: PEPTIDE SYNTHESIS LYOPHILIZERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 61 LATIN AMERICA: PEPTIDE SYNTHESIS LYOPHILIZERS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
6.4 SERVICES
6.4.1 RISING RESEARCH ACTIVITIES IN THE PROTEOMICS, GENOMICS, AND PEPTIDE THERAPEUTICS FIELDS TO DRIVE MARKET GROWTH
TABLE 62 PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 63 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 64 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 65 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 66 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY (Page No. - 101)
7.1 INTRODUCTION
TABLE 67 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
7.2 SOLID-PHASE PEPTIDE SYNTHESIS (SPPS)
7.2.1 EASE OF USE IS A KEY ADVANTAGE ASSOCIATED WITH SPPS TECHNOLOGY
TABLE 68 SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 69 NORTH AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 70 EUROPE: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 71 ASIA PACIFIC: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 72 LATIN AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.3 SOLUTION-PHASE PEPTIDE SYNTHESIS
7.3.1 LARGE QUANTITIES OF HIGH-QUALITY PEPTIDES CAN BE PRODUCED COST EFFECTIVELY WITH THE SOLUTION-PHASE PEPTIDE SYNTHESIS TECHNOLOGY
TABLE 73 SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 74 NORTH AMERICA: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 75 EUROPE: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 76 ASIA PACIFIC: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 77 LATIN AMERICA: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.4 HYBRID & RECOMBINANT TECHNOLOGY
7.4.1 HYBRID & RECOMBINANT METHOD ENABLES THE PRODUCTION OF PEPTIDES WITH HIGHER COMPLEXITY
TABLE 78 HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 79 NORTH AMERICA: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 80 EUROPE: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 81 ASIA PACIFIC: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 82 LATIN AMERICA: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
8 PEPTIDE SYNTHESIS MARKET, BY END USER (Page No. - 110)
8.1 INTRODUCTION
TABLE 83 PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 PEPTIDE SYNTHESIS PRODUCTS ARE MOST WIDELY USED BY PHARMA & BIOTEC COMPANIES FOR DRUG DEVELOPMENT APPLICATIONS
TABLE 84 PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2026 (USD MILLION)
TABLE 85 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 86 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 87 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 88 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
8.3 CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS AND CONTRACT RESEARCH ORGANIZATIONS (CDMOS & CROS)
8.3.1 INCREASING DEMAND FOR COST-EFFECTIVE PEPTIDE SYNTHESIS SERVICES IS DRIVING THE GROWTH OF CDMOS & CROS
TABLE 89 PEPTIDE SYNTHESIS MARKET FOR CDMOS & CROS, BY REGION, 2019-2026 (USD MILLION)
TABLE 90 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CDMOS & CROS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 91 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CDMOS & CROS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 92 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CDMOS & CROS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 93 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CDMOS & CROS, BY COUNTRY, 2019-2026 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 INCREASING FINANCIAL AND REGULATORY SUPPORT FOR RESEARCH TO DRIVE MARKET GROWTH
TABLE 94 PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2026 (USD MILLION)
TABLE 95 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 96 EUROPE: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 97 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 98 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
9 PEPTIDE SYNTHESIS MARKET, BY REGION (Page No. - 119)
9.1 INTRODUCTION
FIGURE 24 PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 99 PEPTIDE SYNTHESIS MARKET, BY REGION, 2019-2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 25 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET SNAPSHOT
TABLE 100 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 101 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 102 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 103 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 104 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 105 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the North American peptide synthesis market
TABLE 106 US: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 107 US: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 108 US: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 109 US: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 110 US: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Availability of research funding in Canada to drive market growth
TABLE 111 CANADA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 112 CANADA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 113 CANADA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 114 CANADA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 115 CANADA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.3 EUROPE
TABLE 116 EUROPE: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 117 EUROPE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 118 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 119 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 120 EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 121 EUROPE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Strong academic base and rising awareness are key growth drivers in Germany
TABLE 122 GERMANY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 123 GERMANY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 124 GERMANY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 125 GERMANY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 126 GERMANY: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 USD MILLION)
9.3.2 UK
9.3.2.1 Growth in life science research to drive market growth
TABLE 127 UK: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 128 UK: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 129 UK: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 130 UK: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 131 UK: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Government funding for proteomics and genomics research to propel market growth
TABLE 132 FRANCE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 133 FRANCE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 134 FRANCE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 135 FRANCE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 136 FRANCE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing life science research to boost the market growth in Italy
TABLE 137 ITALY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 138 ITALY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 139 ITALY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 140 ITALY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 141 ITALY: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising focus on research and innovation to support market growth
TABLE 142 SPAIN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 143 SPAIN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 144 SPAIN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 145 SPAIN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 146 SPAIN: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 USD MILLION)
9.3.6 REST OF EUROPE
TABLE 147 ROE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 148 ROE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 149 ROE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 150 ROE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 151 ROE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.4 ASIA PACIFIC (APAC)
FIGURE 26 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET SNAPSHOT
TABLE 152 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 153 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 154 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 155 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 156 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 157 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China to register the highest growth rate due to increasing investments in R&D
TABLE 158 CHINA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 159 CHINA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 160 CHINA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 161 CHINA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 162 CHINA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Rising collaborations between companies in Japan to propel market growth
TABLE 163 JAPAN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 164 JAPAN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 165 JAPAN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 166 JAPAN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 167 JAPAN: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Government support for scientific research to drive market growth
TABLE 168 INDIA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 169 INDIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 170 INDIA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 171 INDIA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 172 INDIA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.4.4 SOUTH KOREA
9.4.4.1 Growing research efforts in the biopharmaceutical sector to boost market growth
TABLE 173 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 174 SOUTH KOREA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 175 SOUTH KOREA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 176 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 177 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC (ROAPAC)
TABLE 178 ROAPAC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 179 ROAPAC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 180 ROAPAC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 181 ROAPAC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 182 ROAPAC: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 183 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 184 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 185 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 186 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 187 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 188 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Rising government investments in research to support market growth
TABLE 189 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 190 BRAZIL: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 191 BRAZIL: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 192 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 193 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Mexico is the second-largest pharmaceutical market in Latin America
TABLE 194 MEXICO: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 195 MEXICO: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 196 MEXICO: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 197 MEXICO: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 198 MEXICO: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.5.3 REST OF LATIN AMERICA (ROLATAM)
TABLE 199 ROLATAM: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 200 ROLATAM: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 201 ROLATAM: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 202 ROLATAM: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 203 ROLATAM: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWING PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES AND INCREASING R&D ACTIVITIES TO DRIVE MARKET GROWTH
TABLE 204 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019-2026 (USD MILLION)
TABLE 205 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 206 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 207 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
TABLE 208 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019-2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 171)
10.1 OVERVIEW
10.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
FIGURE 27 KEY PLAYER STRATEGIES IN THE PEPTIDE SYNTHESIS MARKET, 2018-2021
10.3 MARKET SHARE ANALYSIS
FIGURE 28 PEPTIDE SYNTHESIS MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
TABLE 209 PEPTIDE SYNTHESIS MARKET: DEGREE OF COMPETITION
10.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 29 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE PEPTIDE SYNTHESIS MARKET, 2018 TO 2020
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 30 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION QUADRANT, 2020
10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 31 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
10.7 COMPANY PRODUCT FOOTPRINT
TABLE 210 PRODUCT/SERVICE PORTFOLIO ANALYSIS: PEPTIDE SYNTHESIS MARKET (2020)
10.8 COMPANY GEOGRAPHIC FOOTPRINT
TABLE 211 GEOGRAPHIC REVENUE MIX: PEPTIDE SYNTHESIS MARKET (2020)
10.9 COMPETITIVE SCENARIO
TABLE 212 PRODUCT & SERVICE LAUNCHES
TABLE 213 DEALS
TABLE 214 OTHER DEVELOPMENTS
11 COMPANY PROFILES (Page No. - 185)
11.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 GENSCRIPT BIOTECH CORPORATION
TABLE 215 GENSCRIPT BIOTECH CORPORATION: BUSINESS OVERVIEW
FIGURE 32 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2020)
11.1.2 THERMO FISHER SCIENTIFIC
TABLE 216 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
11.1.3 MERCK KGAA
TABLE 217 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2020)
11.1.4 BACHEM HOLDING AG
TABLE 218 BACHEM HOLDING AG: BUSINESS OVERVIEW
FIGURE 35 BACHEM HOLDING AG: COMPANY SNAPSHOT (2020)
11.1.5 KANEKA CORPORATION
TABLE 219 KANEKA CORPORATION: BUSINESS OVERVIEW
FIGURE 36 KANEKA CORPORATION: COMPANY SNAPSHOT (2020)
11.1.6 BIOTAGE AB
TABLE 220 BIOTAGE AB: BUSINESS OVERVIEW
FIGURE 37 BIOTAGE AB: COMPANY SNAPSHOT (2020)
11.1.7 SYNGENE INTERNATIONAL LIMITED
TABLE 221 SYNGENE INTERNATIONAL LIMITED: BUSINESS OVERVIEW
FIGURE 38 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2020)
11.1.8 MESA LABORATORIES, INC.
TABLE 222 MESA LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 39 MESA LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
11.1.9 CEM CORPORATION
TABLE 223 CEM CORPORATION: BUSINESS OVERVIEW
11.1.10 PROTEOGENIX
TABLE 224 PROTEOGENIX: BUSINESS OVERVIEW
11.1.11 BIO-SYNTHESIS INC.
TABLE 225 BIO-SYNTHESIS INC.: BUSINESS OVERVIEW
11.1.12 DALTON PHARMA SERVICES
TABLE 226 DALTON PHARMA SERVICES: BUSINESS OVERVIEW
11.1.13 AAPPTEC
TABLE 227 AAPPTEC: BUSINESS OVERVIEW
11.1.14 VIVITIDE
TABLE 228 VIVITIDE: BUSINESS OVERVIEW
11.1.15 ANYGEN CO., LTD.
TABLE 229 ANYGEN CO., LTD.: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 CSBIO
11.2.2 ADVANCED CHEMTECH
11.2.3 LUXEMBOURG BIO TECHNOLOGIES LTD.
11.2.4 JPT PEPTIDE TECHNOLOGIES GMBH
11.2.5 AMBIOPHARM INC.
11.2.6 AURIGENE PHARMACEUTICAL SERVICES LTD.
11.2.7 CORDENPHARMA INTERNATIONAL
11.2.8 CHEMPEP INC.
11.2.9 CPC SCIENTIFIC INC.
11.2.10 PUROLITE PVT.LTD.
12 APPENDIX (Page No. - 231)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS